MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3

Biochemical and Biophysical Research Communications

Volumn 441, Issue 4, 2013, Pages 873-879

  Lu, Yanxin ^a,b   Yue, Xupeng ^b   Cui, Yuanyuan ^a   Zhang, Jufeng ^b   Wang, KeWei ^a,b,c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Biomedical Research Institute   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

Apoptosis; Hepatocellular carcinoma; MiR 124; Proliferation

Indexed keywords

CASPASE 3; MICRORNA 124; STAT3 PROTEIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; WESTERN BLOTTING;

MUS MUSCULUS;

APOPTOSIS; HEPATOCELLULAR CARCINOMA; MIR-124; PROLIFERATION; STAT3;

ANIMALS; APOPTOSIS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; STAT3 TRANSCRIPTION FACTOR;

EID: 84888849526     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.157     Document Type: Article

References (29)

1. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
2. Huang Y., Shen X.J., Zou Q., Wang S.P., Tang S.M., Zhang G.Z. Biological functions of microRNAs: a review. J. Physiol. Biochem. 2011, 67:129-139.
3. Nelson K.M., Weiss G.J. MicroRNAs and cancer: past, present, and potential future. Mol. Cancer Ther. 2008, 7:3655-3660.
4. Lee Y.S., Dutta A. MicroRNAs in cancer. Annu. Rev. Pathol. 2009, 4:199-227.
5. Braconi C., Henry J.C., Kogure T., Schmittgen T., Patel T. The role of microRNAs in human liver cancers. Semin. Oncol. 2011, 38:752-763.
6. Roberts L.R. Sorafenib in liver cancer-just the beginning. N. Engl. J. Med. 2008, 359:420-422.
7. Llovet J.M. Updated treatment approach to hepatocellular carcinoma. J. Gastroenterol. 2005, 40:225-235.
8. Zhu X.M., Wu L.J., Xu J., Yang R., Wu F.S. Let-7c microRNA expression and clinical significance in hepatocellular carcinoma. J. Int. Med. Res. 2012, 39:2323-2329.
9. Noh J.H., Chang Y.G., Kim M.G., Jung K.H., Kim J.K., Bae H.J., Eun J.W., Shen Q., Kim S.J., Kwon S.H., Park W.S., Lee J.Y., Nam S.W. MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Lett. 2013.
10. Yang H., Fang F., Chang R., Yang L. MicroRNA-140-5p suppresses tumor growth and metastasis by targeting TGFBR1 and FGF9 in hepatocellular carcinoma. Hepatology 2013.
11. Gu H., Guo X., Zou L., Zhu H., Zhang J. Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma. Mol. Cell. Biochem. 2013, 375:23-30.
12. Zhang L.Y., Liu M., Li X., Tang H. MiR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3). J. Biol. Chem. 2012, 288:4035-4047.
13. Zhang L., Yang L., Liu X., Chen W., Chang L., Chen L., Loera S., Chu P., Huang W.C., Liu Y.R., Yen Y. MiR-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through NF-kappaB pathways. Hepatology 2012.
14. Budhu A., Jia H.L., Forgues M., Liu C.G., Goldstein D., Lam A., Zanetti K.A., Ye Q.H., Qin L.X., Croce C.M., Tang Z.Y., Wang X.W. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008, 47:897-907.
15. Lang Q., Ling C. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. Biochem. Biophys. Res. Commun. 2012, 426:247-252.
16. Fiorentini C., Fabbri A., Falzano L., Fattorossi A., Matarrese P., Rivabene R., Donelli G. Clostridium difficile toxin B induces apoptosis in intestinal cultured cells. Infect. Immun. 1998, 66:2660-2665.
17. Walters J., Pop C., Scott F.L., Drag M., Swartz P., Mattos C., Salvesen G.S., Clark A.C. A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis. Biochem. J. 2009, 424:335-345.
18. Visvanathan J., Lee S., Lee B., Lee J.W., Lee S.K. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev. 2007, 21:744-749.
19. Chandrasekar V., Dreyer J.L. MicroRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol. Cell. Neurosci. 2009, 42:350-362.
20. Li K.K., Pang J.C., Ching A.K., Wong C.K., Kong X., Wang Y., Zhou L., Chen Z., Ng H.K. MiR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum. Pathol. 2009, 40:1234-1243.
21. Silber J., Lim D.A., Petritsch C., Persson A.I., Maunakea A.K., Yu M., Vandenberg S.R., Ginzinger D.G., James C.D., Costello J.F., Bergers G., Weiss W.A., Alvarez-Buylla A., Hodgson J.G. MiR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008, 6:14.
22. Lv X.B., Jiao Y., Qing Y., Hu H., Cui X., Lin T., Song E., Yu F. MiR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro. Chin. J. Cancer 2011, 30:821-830.
23. Zheng F., Liao Y.J., Cai M.Y., Liu Y.H., Liu T.H., Chen S.P., Bian X.W., Guan X.Y., Lin M.C., Zeng Y.X., Kung H.F., Xie D. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 2011, 61:278-289.
24. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
25. Bowman T., Garcia R., Turkson J., Jove R. STATs in oncogenesis. Oncogene 2000, 19:2474-2488.
26. Darnell J.E. STATs and gene regulation. Science 1997, 277:1630-1635.
27. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Stat3 as an oncogene. Cell 1999, 98:295-303.
28. Levy D.E., Inghirami G. STAT3: a multifaceted oncogene. Proc. Natl. Acad. Sci. USA 2006, 103:10151-10152.
29. Calvisi D.F., Ladu S., Gorden A., Farina M., Conner E.A., Lee J.S., Factor V.M., Thorgeirsson S.S. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 2006, 130:1117-1128.